⭐️⭐️⭐️⭐️⭐️ "A total no brainer"

⭐️⭐️⭐️⭐️⭐️ "Love this, so easy."

Spots is the easy way to track your skin, mole and cancer changes.

Spots Global Cancer Trial Database for stage iii colon cancer

Every month we try and update this database with for stage iii colon cancer cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Study titleNCT IDConditionsInterventionsEligibilityOrganizationLink
Cytokine-induced Killer Cell Immunotherapy for Surgical Resected Stage III Colorectal Cancer Patients After ChemotherapyNCT02280278
Stage III Colon...
Radical surgery
Adjuvant chemot...
Cytokine-induce...
18 Years - 70 YearsSun Yat-sen University
Combination Chemotherapy With or Without Bevacizumab Compared With Bevacizumab Alone in Treating Patients With Advanced or Metastatic Colorectal Cancer That Has Been Previously TreatedNCT00025337
Adenocarcinoma ...
Adenocarcinoma ...
Recurrent Colon...
Recurrent Recta...
Stage III Colon...
Stage III Recta...
Stage IV Colon ...
Stage IV Rectal...
bevacizumab
oxaliplatin
leucovorin calc...
fluorouracil
18 Years - National Cancer Institute (NCI)
Sorafenib, Cetuximab, and Irinotecan in Treating Patients With Advanced or Metastatic Colorectal CancerNCT00134069
Recurrent Colon...
Recurrent Recta...
Stage III Colon...
Stage III Recta...
Stage IV Colon ...
Stage IV Rectal...
sorafenib tosyl...
cetuximab
irinotecan hydr...
18 Years - National Cancer Institute (NCI)
Combination Chemotherapy and Cetuximab as First-Line Therapy in Treating Patients With Advanced and/or Metastatic Colorectal CancerNCT00640081
Colorectal Canc...
cetuximab
capecitabine
fluorouracil
leucovorin calc...
oxaliplatin
immunohistochem...
laboratory biom...
18 Years - 100 YearsMedical Research Council
Gemcitabine in Treating Patients With Advanced Colorectal CancerNCT00007943
Colorectal Canc...
gemcitabine hyd...
18 Years - 120 YearsWake Forest University Health Sciences
Trastuzumab Plus R115777 in Treating Patients With Advanced or Metastatic CancerNCT00005842
Cancer
trastuzumab
tipifarnib
18 Years - National Cancer Institute (NCI)
Cetuximab and Irinotecan in Treating Patients With Advanced Colorectal CancerNCT00005076
Colorectal Canc...
cetuximab
irinotecan hydr...
18 Years - University of Alabama at Birmingham
Chemotherapy With Raltitrexed and Fluorouracil in Treating Patients With Advanced Colorectal CancerNCT00002828
Colorectal Canc...
fluorouracil
raltitrexed
18 Years - Memorial Sloan Kettering Cancer Center
Combination Chemotherapy in Treating Patients With Colorectal CancerNCT00006103
Colorectal Canc...
fluorouracil
irinotecan hydr...
leucovorin calc...
- Alliance for Clinical Trials in Oncology
Immunotherapy With CEA(6D) VRP Vaccine (AVX701) in Patients With Stage III Colorectal CancerNCT01890213
Stage III Colon...
AVX701
18 Years - Duke University
Combination Chemotherapy and Radiation Therapy in Treating Patients With Colorectal CancerNCT00002801
Colorectal Canc...
leucovorin calc...
tegafur-uracil
radiation thera...
18 Years - National Cancer Institute (NCI)
High-Dose Fluorouracil With or Without Leucovorin Compared With Standard Fluorouracil Plus Leucovorin Following Surgery in Treating Patients With Stage III Colon CancerNCT00004150
Colorectal Canc...
fluorouracil
leucovorin calc...
adjuvant therap...
18 Years - National Cancer Institute (NCI)
SU5416 in Treating Patients With Metastatic or Locally Recurrent Colorectal CancerNCT00006001
Colorectal Canc...
semaxanib
18 Years - National Cancer Institute (NCI)
Fluorouracil and Leucovorin With or Without Irinotecan in Treating Patients Following Surgery for Stage III Colorectal CancerNCT00026273
Colorectal Canc...
FOLFIRI regimen
fluorouracil
irinotecan hydr...
leucovorin calc...
18 Years - 75 YearsPfizer
Suberoylanilide Hydroxamic Acid, Fluorouracil, Leucovorin, and Oxaliplatin in Treating Patients With Progressive Metastatic or Unresectable Colorectal Cancer or Other Solid TumorsNCT00138177
Recurrent Colon...
Recurrent Recta...
Stage III Colon...
Stage III Recta...
Stage IV Colon ...
Stage IV Rectal...
Unspecified Adu...
oxaliplatin
leucovorin calc...
vorinostat
fluorouracil
18 Years - National Cancer Institute (NCI)
GM-CSF and Combination Chemotherapy in Treating Patients Who Are Undergoing Surgery for Stage II or Stage III Colon CancerNCT00262808
Colorectal Canc...
sargramostim
fluorouracil
leucovorin calc...
oxaliplatin
adjuvant therap...
conventional su...
neoadjuvant the...
18 Years - University of Rochester
Biomarker-Guided Fluorouracil in Treating Patients With Colorectal Cancer Receiving Combination ChemotherapyNCT01164215
Colorectal Canc...
Diarrhea
Neutropenia
fluorouracil
leucovorin
oxaliplatin
- UNC Lineberger Comprehensive Cancer Center
Sorafenib, Cetuximab, and Irinotecan in Treating Patients With Advanced or Metastatic Colorectal CancerNCT00134069
Recurrent Colon...
Recurrent Recta...
Stage III Colon...
Stage III Recta...
Stage IV Colon ...
Stage IV Rectal...
sorafenib tosyl...
cetuximab
irinotecan hydr...
18 Years - National Cancer Institute (NCI)
Biological Therapy With Combination Chemotherapy in Patients With Colorectal CancerNCT00003063
Colorectal Canc...
recombinant int...
fluorouracil
leucovorin calc...
levamisole hydr...
- 75 YearsNational Cancer Institute (NCI)
Lymphatic Mapping and Sentinel Lymph Node Biopsy in the Treatment of Colorectal CancerNCT00005640
Colorectal Canc...
Preoperative En...
Technetium Tc 9...
Gamma Probe
Biopsy of Senti...
18 Years - H. Lee Moffitt Cancer Center and Research Institute
Vaccine Therapy in Treating Patients With Stage II or Stage III Colon Cancer That Has Been Removed During SurgeryNCT00016133
Colorectal Canc...
BCG vaccine
autologous tumo...
fluorouracil
leucovorin calc...
adjuvant therap...
21 Years - 85 YearsNational Cancer Institute (NCI)
Fluorouracil and Oxaliplatin With or Without Panitumumab In Treating Patients With High-Risk Colon Cancer That Can Be Removed by SurgeryNCT00647530
Colorectal Canc...
panitumumab
capecitabine
fluorouracil
oxaliplatin
18 Years - University of Birmingham
Moderate Physical Activity in Helping Patients Recover Physically and Emotionally From Stage II Or Stage III Colorectal CancerNCT00373022
Anxiety Disorde...
Colorectal Canc...
Depression
Psychosocial Ef...
exercise interv...
flow cytometry
laboratory biom...
management of t...
psychosocial as...
quality-of-life...
18 Years - University of Arizona
Genetic Trial to Study Diarrhea in Patients With Stage III Colon Cancer Who Are Receiving ChemotherapyNCT00048971
Colorectal Canc...
Diarrhea
Neutropenia
mutation analys...
polymorphic mic...
18 Years - Alliance for Clinical Trials in Oncology
Combination Chemotherapy and Cetuximab as First-Line Therapy in Treating Patients With Advanced and/or Metastatic Colorectal CancerNCT00640081
Colorectal Canc...
cetuximab
capecitabine
fluorouracil
leucovorin calc...
oxaliplatin
immunohistochem...
laboratory biom...
18 Years - 100 YearsMedical Research Council
OSI-7904L and Oxaliplatin in Treating Patients With Refractory or Recurrent Advanced Colorectal CancerNCT00081237
Colorectal Canc...
OSI-7904L
oxaliplatin
18 Years - European Organisation for Research and Treatment of Cancer - EORTC
Genetic Study in Patients With Stage II or Stage III Colon CancerNCT00003833
Colorectal Canc...
DNA stability a...
gene mapping
- 69 YearsAlliance for Clinical Trials in Oncology
Genetic Study of Young Patients With Colorectal CancerNCT00044967
Colorectal Canc...
microsatellite ...
18 Years - 49 YearsAlliance for Clinical Trials in Oncology
Dose Dense Therapy and Bevacizumab in Solid Tumors and Colorectal CancerNCT00296062
Colorectal Canc...
Unspecified Adu...
bevacizumab
capecitabine
irinotecan hydr...
oxaliplatin
18 Years - Case Comprehensive Cancer Center
Disease Management Program or Usual Care in Patients With Stage III or Stage IV Lung Cancer, Pancreatic Cancer, Ovarian Cancer, or Colorectal Cancer, and Their CaregiversNCT00684801
Colorectal Canc...
Lung Cancer
Ovarian Cancer
Pancreatic Canc...
questionnaire a...
quality-of-life...
18 Years - Case Comprehensive Cancer Center
Fluorouracil Plus Leucovorin With or Without Oxaliplatin in Treating Patients With Stage II or Stage III Colon CancerNCT00004931
Stage II Colon ...
Stage III Colon...
leucovorin calc...
fluorouracil
oxaliplatin
laboratory biom...
- National Cancer Institute (NCI)
Genetic Study of Patients and Families With a History of Colorectal CancerNCT00003648
Colorectal Canc...
DNA stability a...
gene rearrangem...
- Alliance for Clinical Trials in Oncology
Lymphatic Mapping, Sentinel Lymph Node Analysis, and Blood Tests in Detecting and Predicting Early Micrometastases in Patients With Colorectal CancerNCT00625625
Colorectal Canc...
isosulfan blue
polymerase chai...
diagnostic labo...
immunohistochem...
diagnostic lymp...
therapeutic con...
therapeutic lym...
18 Years - National Cancer Institute (NCI)
Oxaliplatin, Irinotecan, and Capecitabine in Treating Patients With Advanced or Metastatic Colorectal Cancer That Cannot Be Removed By SurgeryNCT00217711
Colorectal Canc...
Capecitabine
irinotecan hydr...
oxaliplatin
18 Years - 70 YearsSwiss Group for Clinical Cancer Research
Octreotide as Palliative Therapy for Cancer-Related Bowel Obstruction That Cannot Be Removed by SurgeryNCT00004895
Colorectal Canc...
Constipation, I...
Extrahepatic Bi...
Gastric Cancer
Gastrointestina...
Nausea and Vomi...
Ovarian Cancer
Pancreatic Canc...
Peritoneal Cavi...
Small Intestine...
octreotide acet...
18 Years - Northwestern University
Leucovorin and Fluorouracil Compared With Observation in Treating Patients With Colorectal Cancer That Has Been Surgically RemovedNCT00005586
Colorectal Canc...
L-leucovorin
fluorouracil
adjuvant therap...
18 Years - National Cancer Institute (NCI)
Combination Chemotherapy With or Without Cetuximab in Treating Patients With Stage III Colon Cancer That Was Completely Removed By SurgeryNCT00265811
Colorectal Canc...
Folfox
Cetuximab
18 Years - 74 YearsFederation Francophone de Cancerologie Digestive
Radiolabeled Monoclonal Antibody Therapy in Treating Patients With Gastrointestinal CancerNCT00025532
Colorectal Canc...
Esophageal Canc...
Gastric Cancer
Pancreatic Canc...
iodine I 131 mo...
19 Years - University of California, San Francisco
Cyclophosphamide Plus Vaccine Therapy in Treating Patients With Advanced CancerNCT00002475
Breast Cancer
Colorectal Canc...
Kidney Cancer
Lung Cancer
Malignant Mesot...
Pancreatic Canc...
allogeneic tumo...
autologous tumo...
recombinant int...
recombinant int...
sargramostim
cyclophosphamid...
18 Years - National Cancer Institute (NCI)
Fluorouracil, Semustine, and Vincristine Compared With BCG in Treating Patients With Dukes' B or Dukes' C Colon Cancer That Has Been Removed By SurgeryNCT00427570
Colorectal Canc...
BCG vaccine
biological ther...
fluorouracil
semustine
vincristine sul...
- 79 YearsNational Cancer Institute (NCI)
Quality of Life and Survivorship Care in Patients Undergoing Hyperthermic Intraperitoneal Chemotherapy (HIPEC)NCT01126346
Advanced Malign...
Carcinoma of th...
Ovarian Sarcoma
Ovarian Stromal...
Pseudomyxoma Pe...
Recurrent Colon...
Recurrent Malig...
Recurrent Ovari...
Recurrent Ovari...
Stage III Colon...
Stage III Ovari...
Stage III Ovari...
Stage IV Colon ...
Stage IV Ovaria...
Stage IV Ovaria...
Unspecified Chi...
HIPEC Orientati...
Consultation wi...
Questionnaires
- Wake Forest University Health Sciences
A Phase I/II Study With CEA(6D) VRP Vaccine in Patients With Advanced or Metastatic CEA-Expressing MalignanciesNCT00529984
Colorectal Canc...
Breast Cancer
Lung Cancer
Pancreatic Canc...
Colon Cancer
AVX701
AVX701
AVX701
AVX701
AVX701
18 Years - AlphaVax, Inc.
Radiation Therapy Plus Irinotecan in Treating Patients With Colon CancerNCT00003344
Colorectal Canc...
irinotecan hydr...
radiation thera...
18 Years - 120 YearsMedical University of South Carolina
Combination Chemotherapy for 3 Months or 6 Months in Treating Patients With Stage III Colon CancerNCT00958737
Colorectal Canc...
FOLFOX regimen
CAPOX
18 Years - GERCOR - Multidisciplinary Oncology Cooperative Group
Study of Tumor Samples From Patients With Stage III Colon Cancer Who Have Undergone Surgery and ChemotherapyNCT00918827
Colorectal Canc...
- Translational Research Center for Medical Innovation, Kobe, Hyogo, Japan
Standard Therapy With or Without Surgery and Mitomycin C in Treating Patients With Advanced Limited Peritoneal Dissemination of Colon CancerNCT01167725
Colorectal Canc...
bevacizumab
cetuximab
FOLFIRI regimen
FOLFOX regimen
capecitabine
fluorouracil
irinotecan hydr...
leucovorin calc...
mitomycin C
oxaliplatin
therapeutic con...
18 Years - National Cancer Institute (NCI)
Resveratrol in Treating Patients With Colorectal Cancer That Can Be Removed By SurgeryNCT00433576
Adenocarcinoma ...
Adenocarcinoma ...
Stage I Colon C...
Stage I Rectal ...
Stage II Colon ...
Stage II Rectal...
Stage III Colon...
Stage III Recta...
resveratrol
pharmacological...
laboratory biom...
18 Years - National Cancer Institute (NCI)
Making Decisions About Participating in a Cancer Clinical Trial for Patients With Stage II, Stage III, or Stage IV Pancreatic Cancer or Stage III or Stage IV Colon Cancer or Rectal CancerNCT00478010
Colorectal Canc...
Pancreatic Canc...
Psychosocial Ef...
counseling inte...
study of socioe...
psychosocial as...
quality-of-life...
18 Years - 120 YearsSidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Quality of Life and Survivorship Care in Patients Undergoing Hyperthermic Intraperitoneal Chemotherapy (HIPEC)NCT01126346
Advanced Malign...
Carcinoma of th...
Ovarian Sarcoma
Ovarian Stromal...
Pseudomyxoma Pe...
Recurrent Colon...
Recurrent Malig...
Recurrent Ovari...
Recurrent Ovari...
Stage III Colon...
Stage III Ovari...
Stage III Ovari...
Stage IV Colon ...
Stage IV Ovaria...
Stage IV Ovaria...
Unspecified Chi...
HIPEC Orientati...
Consultation wi...
Questionnaires
- Wake Forest University Health Sciences
Differences in Timely Cancer Diagnosis in African American and Caucasian Patients With Newly Diagnosed Colorectal CancerNCT00856115
Colorectal Canc...
medical chart r...
questionnaire a...
study of socioe...
survey administ...
21 Years - Case Comprehensive Cancer Center
Follow-Up Study of Patients Who Have Undergone Surgery for Stage I, Stage II, or Stage III Colorectal CancerNCT00560365
Colorectal Canc...
laboratory biom...
computed tomogr...
magnetic resona...
quality-of-life...
50 Years - National Cancer Institute (NCI)
Massage Therapy in Treating the Symptoms of Patients With Locally Advanced or Metastatic CancerNCT00253708
Cancer
management of t...
massage therapy
pain therapy
psychosocial as...
quality-of-life...
18 Years - 120 YearsBeth Israel Deaconess Medical Center
Gemcitabine in Treating Patients With Advanced Colorectal CancerNCT00007943
Colorectal Canc...
gemcitabine hyd...
18 Years - 120 YearsWake Forest University Health Sciences
Alvespimycin Hydrochloride in Treating Patients With Metastatic or Unresectable Solid TumorsNCT00089362
Male Breast Can...
Recurrent Adeno...
Recurrent Basal...
Recurrent Breas...
Recurrent Colon...
Recurrent Esthe...
Recurrent Gastr...
Recurrent Inver...
Recurrent Lymph...
Recurrent Lymph...
Recurrent Melan...
Recurrent Metas...
Recurrent Midli...
Recurrent Mucoe...
Recurrent Ovari...
Recurrent Prost...
Recurrent Renal...
Recurrent Saliv...
Recurrent Squam...
Recurrent Squam...
Recurrent Squam...
Recurrent Squam...
Recurrent Squam...
Recurrent Squam...
Recurrent Verru...
Recurrent Verru...
Stage III Adeno...
Stage III Basal...
Stage III Colon...
Stage III Esthe...
Stage III Gastr...
Stage III Inver...
Stage III Lymph...
Stage III Lymph...
Stage III Melan...
Stage III Midli...
Stage III Mucoe...
Stage III Ovari...
Stage III Renal...
Stage III Saliv...
Stage III Squam...
Stage III Squam...
Stage III Squam...
Stage III Squam...
Stage III Squam...
Stage III Squam...
Stage III Verru...
Stage III Verru...
Stage IIIB Brea...
Stage IIIC Brea...
Stage IV Adenoi...
Stage IV Basal ...
Stage IV Breast...
Stage IV Colon ...
Stage IV Esthes...
Stage IV Gastri...
Stage IV Invert...
Stage IV Lympho...
Stage IV Lympho...
Stage IV Melano...
Stage IV Midlin...
Stage IV Mucoep...
Stage IV Ovaria...
Stage IV Prosta...
Stage IV Renal ...
Stage IV Saliva...
Stage IV Squamo...
Stage IV Squamo...
Stage IV Squamo...
Stage IV Squamo...
Stage IV Squamo...
Stage IV Squamo...
Stage IV Verruc...
Stage IV Verruc...
Unspecified Adu...
Untreated Metas...
alvespimycin hy...
laboratory biom...
pharmacological...
18 Years - National Cancer Institute (NCI)
Growth Factor Levels in the Blood of Patients Undergoing Radiation Therapy for Epithelial CancerNCT00897793
Breast Cancer
Colorectal Canc...
Head and Neck C...
Lung Cancer
Prostate Cancer
venipuncture
radiation thera...
18 Years - Vanderbilt-Ingram Cancer Center
Combination Chemotherapy and Radiation Therapy in Treating Patients With Colorectal CancerNCT00002801
Colorectal Canc...
leucovorin calc...
tegafur-uracil
radiation thera...
18 Years - National Cancer Institute (NCI)
Perioperative Chemotherapy in Treating Patients With Colon Cancer That Can Be Surgically RemovedNCT00002525
Colorectal Canc...
fluorouracil
leucovorin calc...
18 Years - Eastern Cooperative Oncology Group
Combination Chemotherapy in Treating Patients With Advanced Colorectal CancerNCT00003594
Colorectal Canc...
irinotecan
fluorouracil
leucovorin calc...
oxaliplatin
18 Years - Alliance for Clinical Trials in Oncology
Biological Therapy With Combination Chemotherapy in Patients With Colorectal CancerNCT00003063
Colorectal Canc...
recombinant int...
fluorouracil
leucovorin calc...
levamisole hydr...
- 75 YearsNational Cancer Institute (NCI)
LMB-9 Immunotoxin in Treating Patients With Advanced Pancreatic, Esophageal, Stomach, Colon, or Rectal CancerNCT00010270
Colorectal Canc...
Esophageal Canc...
Gastric Cancer
Pancreatic Canc...
LMB-9 immunotox...
18 Years - National Cancer Institute (NCI)
DJ-927 as Second-Line Therapy in Treating Patients With Progressive Locally Advanced or Metastatic Colorectal AdenocarcinomaNCT00080834
Colorectal Canc...
DJ-927
18 Years - Daiichi Sankyo
Vaccine Therapy in Treating Patients With Cancer of the Gastrointestinal TractNCT00012246
Colorectal Canc...
Esophageal Canc...
Extrahepatic Bi...
Gallbladder Can...
Gastric Cancer
Pancreatic Canc...
Small Intestine...
carcinoembryoni...
incomplete Freu...
sargramostim
18 Years - The University of Texas Medical Branch, Galveston
Irinotecan and Capecitabine in Treating Patients With Solid TumorsNCT00003867
Cancer
capecitabine
irinotecan hydr...
18 Years - 120 YearsMontefiore Medical Center
Perioperative Chemotherapy in Treating Patients With Colon Cancer That Can Be Surgically RemovedNCT00002525
Colorectal Canc...
fluorouracil
leucovorin calc...
18 Years - Eastern Cooperative Oncology Group
S-1 and Bevacizumab in Treating Patients With Colorectal Cancer That is Recurrent or Cannot Be Removed by SurgeryNCT00974389
Colorectal Canc...
bevacizumab
tegafur-gimerac...
20 Years - 80 YearsNational Cancer Institute (NCI)
Epothilone D as Second-Line Treatment for Patients With Advanced or Metastatic Refractory Colorectal CancerNCT00077259
Colorectal Canc...
epothilone D
18 Years - Memorial Sloan Kettering Cancer Center
DJ-927 as Second-Line Therapy in Treating Patients With Progressive Locally Advanced or Metastatic Colorectal AdenocarcinomaNCT00080834
Colorectal Canc...
DJ-927
18 Years - Daiichi Sankyo
Skin Biopsies and DNA Analysis in Patients Receiving Irinotecan or Gemcitabine For Advanced Solid TumorsNCT00369109
Breast Cancer
Colorectal Canc...
Pancreatic Canc...
biologic sample...
immunohistochem...
laboratory biom...
biopsy
18 Years - Barbara Ann Karmanos Cancer Institute
Fluorouracil, Semustine, and Vincristine Compared With BCG in Treating Patients With Dukes' B or Dukes' C Colon Cancer That Has Been Removed By SurgeryNCT00427570
Colorectal Canc...
BCG vaccine
biological ther...
fluorouracil
semustine
vincristine sul...
- 79 YearsNational Cancer Institute (NCI)
Genetic Study in Patients With Stage II or Stage III Colon CancerNCT00003833
Colorectal Canc...
DNA stability a...
gene mapping
- 69 YearsAlliance for Clinical Trials in Oncology
Prognostic Value of the Immunoscore® Colon Test for Disease Free Survival Stratification in Stage III Patients Under Oxaliplatin TreatmentNCT03422601
Colorectal Canc...
Stage III Colon...
Immunoscore tes...
18 Years - GERCOR - Multidisciplinary Oncology Cooperative Group
Laparoscopic-Assisted Surgery Compared With Open Surgery in Treating Patients With Colon CancerNCT00002575
Colorectal Canc...
conventional su...
laparoscopic su...
18 Years - Alliance for Clinical Trials in Oncology
Genetic Study of Familial Factors in Patients With Colon CancerNCT00055848
Colorectal Canc...
cytogenetic ana...
gene mapping
microarray anal...
- 70 YearsAlliance for Clinical Trials in Oncology
Lymphatic Mapping, Sentinel Lymph Node Analysis, and Blood Tests in Detecting and Predicting Early Micrometastases in Patients With Colorectal CancerNCT00625625
Colorectal Canc...
isosulfan blue
polymerase chai...
diagnostic labo...
immunohistochem...
diagnostic lymp...
therapeutic con...
therapeutic lym...
18 Years - National Cancer Institute (NCI)
MRI in Predicting Response in Patients Receiving Combination Chemotherapy and Bevacizumab For Advanced or Metastatic Colorectal CancerNCT00602329
Colorectal Canc...
bevacizumab
fluorouracil
leucovorin calc...
oxaliplatin
18 Years - 120 YearsAbramson Cancer Center at Penn Medicine
Palliative Chemotherapy in Treating Patients With Advanced Colorectal CancerNCT00002893
Colorectal Canc...
fluorouracil
leucovorin calc...
raltitrexed
- National Cancer Institute (NCI)
Cetuximab and Simvastatin in Treating Patients With Advanced or Metastatic Colorectal CancerNCT01190462
Colorectal Canc...
cetuximab
simvastatin
laboratory biom...
18 Years - National Cancer Institute (NCI)
Quality of Life and Survivorship Care in Patients Undergoing Hyperthermic Intraperitoneal Chemotherapy (HIPEC)NCT01126346
Advanced Malign...
Carcinoma of th...
Ovarian Sarcoma
Ovarian Stromal...
Pseudomyxoma Pe...
Recurrent Colon...
Recurrent Malig...
Recurrent Ovari...
Recurrent Ovari...
Stage III Colon...
Stage III Ovari...
Stage III Ovari...
Stage IV Colon ...
Stage IV Ovaria...
Stage IV Ovaria...
Unspecified Chi...
HIPEC Orientati...
Consultation wi...
Questionnaires
- Wake Forest University Health Sciences
Calcium Gluconate and Magnesium Sulfate in Preventing Neurotoxicity in Patients With Colon Cancer or Rectal Cancer Receiving Oxaliplatin-Based Combination ChemotherapyNCT01099449
Chemotherapeuti...
Colorectal Canc...
Neuropathy
Neurotoxicity
calcium glucona...
magnesium sulfa...
placebo
oxaliplatin
18 Years - Alliance for Clinical Trials in Oncology
Patient-Reported Outcomes in Long-Term Survivors of Colon and Rectal CancersNCT00410579
Colorectal Canc...
Fatigue
Long-term Effec...
Pain
Psychosocial Ef...
Telephone inter...
- NSABP Foundation Inc
Logo

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

spots app storespots app store

Join others from around the world: